These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27686017)

  • 21. From current status to optimization of HCV treatment: Recommendations from an expert panel.
    Craxì A; Perno CF; Viganò M; Ceccherini-Silberstein F; Petta S;
    Dig Liver Dis; 2016 Sep; 48(9):995-1005. PubMed ID: 27388261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Considerations for Unique Patient Populations With HCV Genotype 1 Infection.
    Toussaint-Miller KA; Andres J
    Ann Pharmacother; 2015 Sep; 49(9):1015-30. PubMed ID: 26139639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome.
    Boesecke C; Ingiliz P; Reiberger T; Stellbrink HJ; Bhagani S; Page E; Mauss S; Lutz T; Voigt E; Guiguet M; Valantin MA; Baumgarten A; Nelson M; Vogel M; Rockstroh JK;
    Infection; 2016 Feb; 44(1):93-101. PubMed ID: 26481253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients.
    Soriano V; Sherman KE; Rockstroh J; Dieterich D; Back D; Sulkowski M; Peters M
    AIDS; 2011 Nov; 25(18):2197-208. PubMed ID: 21866039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in the treatment of HIV/HCV coinfection in adults.
    Schlabe S; Rockstroh JK
    Expert Opin Pharmacother; 2018 Jan; 19(1):49-64. PubMed ID: 29252031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
    Saab S; Hunt DR; Stone MA; McClune A; Tong MJ
    Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms.
    Cooper CL; Klein MB
    HIV Med; 2014 Nov; 15(10):621-4. PubMed ID: 24802099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy.
    Milazzo L; Lai A; Calvi E; Ronzi P; Micheli V; Binda F; Ridolfo AL; Gervasoni C; Galli M; Antinori S; Sollima S
    HIV Med; 2017 Apr; 18(4):284-291. PubMed ID: 27477612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine.
    Hüsing A; Kabar I; Schmidt HH; Heinzow HS
    Int J Mol Sci; 2015 Aug; 16(8):18033-53. PubMed ID: 26251895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of new treatment options for hepatitis C virus infection in liver transplantation.
    Righi E; Londero A; Carnelutti A; Baccarani U; Bassetti M
    World J Gastroenterol; 2015 Oct; 21(38):10760-75. PubMed ID: 26478668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating HCV in HIV 2013: on the cusp of change.
    Martel-Laferrière V; Dieterich DT
    Liver Int; 2014 Feb; 34 Suppl 1():53-9. PubMed ID: 24373079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV-coinfected individuals.
    Klein MB; Rollet KC; Hull M; Cooper C; Walmsley S; Conway B; Pick N;
    Antivir Ther; 2013; 18(5):717-21. PubMed ID: 23211632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials.
    Shafran SD
    Clin Infect Dis; 2015 Oct; 61(7):1127-34. PubMed ID: 26060286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current treatment options for hepatitis C patients co-infected with HIV.
    Rockstroh JK; Hardy WD
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):689-95. PubMed ID: 26799571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.
    Uemura H; Tsukada K; Mizushima D; Aoki T; Watanabe K; Kinai E; Teruya K; Gatanaga H; Kikuchi Y; Sugiyama M; Mizokami M; Oka S
    PLoS One; 2017; 12(10):e0186255. PubMed ID: 29045448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.
    Steininger K; Boyd A; Dupke S; Krznaric I; Carganico A; Munteanu M; Neifer S; Schuetze M; Obermeier M; Arasteh K; Baumgarten A; Ingiliz P
    J Viral Hepat; 2017 Oct; 24(10):832-839. PubMed ID: 28439936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV-decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list.
    Bonacci M; Londoño MC; Esforzado N; Forns X; Sotoca JM; Campistol JM
    Transpl Int; 2015 Nov; 28(11):1345-9. PubMed ID: 26073850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of a sexually transmitted hepatitis C virus protease inhibitor-resistance variant in a human immunodeficiency virus-infected homosexual man.
    Franco S; Tural C; Nevot M; Moltó J; Rockstroh JK; Clotet B; Martinez MA
    Gastroenterology; 2014 Sep; 147(3):599-601.e1. PubMed ID: 24859204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hepatitis C in patients with cirrhosis: remaining challenges for direct-acting antiviral therapy.
    Majumdar A; Kitson MT; Roberts SK
    Drugs; 2015 May; 75(8):823-34. PubMed ID: 25943281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.